This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Breaking Into Medical Sales: Gina Torres’s Journey from Nurse to Industry Expert In this inspiring episode, Gina Torres, a seasoned peripheral vascular representative, shares her incredible transition from a peripheral vascular nurse to a top medical device sales expert at Shockwave. Discover how she leveraged her clinical background to drive innovation and improve patient outcomes, particularly in preventing amputations for those with peripheral arterial disease.
I asked if I could purchase the brace myself and bring it to the surgery. The answer was an unequivocal no: the health insurers contracted rate required me to purchase the brace from the hospital as part of the procedure. The post A 2,100% Markup: My Battle with a Vastly Overpriced Knee Brace and U.S. Healthcare appeared first on MedCity News.
Bristol Myers Squibb has agreed a merger with 2seventy bio in a deal worth approximately $286 million. A year ago, 2seventy decided to exclusively focus on unlocking the value of Abecma, with the goal of delivering more time for people living with multiple myeloma and maximizing value for all stakeholders, stated Chip Baird, Chief Executive Officer, 2seventy bio.
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
Table of Contents The Impact of a Pharma Ad Ban on TV Digital Marketing as a Primary Alternative Leveraging Data-Driven Advertising Strategies Strengthening Direct-to-Consumer (DTC) Engagement The Impact of a Pharma Ad Ban on TV The potential for a pharma ad ban on TV has sparked intense discussions among marketing executives. If regulations change, pharmaceutical brands must rethink their advertising strategies to maintain visibility and patient engagement.
With $500 billion allocated to the Stargate initiative, just imagine what could be done if 10% of that focused on women, who make up 51% of the population. The post What If Part of the $500 Billion AI Allocation Was Focused On Womens Health? appeared first on MedCity News.
With $500 billion allocated to the Stargate initiative, just imagine what could be done if 10% of that focused on women, who make up 51% of the population. The post What If Part of the $500 Billion AI Allocation Was Focused On Womens Health? appeared first on MedCity News.
MSD has announced it has opened a new $1 billion vaccine manufacturing facility at its site in Durham, North Carolina, US. “Expanding our state-of-the-art manufacturing facility in Durham marks a significant milestone in our efforts to strengthen our production and manufacturing capabilities in the US,” commented Sanat Chattopadhyay, Executive Vice President and President, Merck Manufacturing Division.
Introduction Pharmaceutical companies are investing heavily in digital advertising , and PPC campaign optimization is key to maximizing ROI while staying compliant. With strict regulations, increasing competition, and evolving ad platform policies, running a successful PPC campaign in pharma isnt as straightforward as in other industries. So, how can pharma brands ensure their Google Ads, LinkedIn campaigns, and paid social media ads are effective?
Healthcare organizations are starting to implement AI agents autonomous, task-specific systems designed to perform functions with little or no human intervention. While initial adoption is focused mainly on non-clinical areas like scheduling and prior authorizations, experts predict that AI agents could eventually play a role in clinical decision-making, provided they meet rigorous safety and reliability standards.
Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.
HHS head Robert F. Kennedy Jr. has long been an opponent of pharma influence in government. U.S. lawmakers are asking whether unofficial Mar-a-Lago meetings point to a change of heart.
Cedar Knolls, NJ March 12th, 2025 Nuvera, part of Inizio Engage, has launched an expanded set of data led, insights-driven client solutions and strengthened its dynamic leadership team under the guidance of Derek Cothran, all showcased in its newly launched website. Nuvera is a leading consulting firm dedicated to designing, building, and measuring patient and HCP treatment experiences for rare diseases, specialty medicines, and cell and gene therapeutics.
Table of Contents Understanding the Role of AI in Pharma Marketing Key Benefits of AI Integration in Pharma Marketing AI-Powered Strategies for Pharma Marketers Overcoming Challenges in AI Adoption Understanding the Role of AI in Pharma Marketing The pharmaceutical industry is undergoing a digital transformation, and AI in pharma marketing is at the forefront of this evolution.
Roche will share in developing and commercializing petrelintide, a clinical-stage Zealand Pharma drug that activates the amylin receptor to spark weight loss. This agreement represents the highest total financial consideration in the obesity field to date. The post Roche Puts Up $1.65B to Partner With Zealand on Future Foundational Therapy for Obesity appeared first on MedCity News.
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Introduction Social media advertising has become an essential part of pharmaceutical marketing, offering direct access to healthcare professionals (HCPs), patients, and caregivers. However, paid social media campaigns in the pharmaceutical industry come with unique challenges, from strict regulatory guidelines to platform restrictions and audience targeting complexities.
While the drop in drug overdose deaths is promising, and could potentially be partially attributed to the efforts of the federal government, we must remain cognizant about the sheer number of lives we continue to lose every year to overdose. The post Buprenorphine Access Still Lags, Even After Major Federal Policy Changes appeared first on MedCity News.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Introduction Pharma marketing is constantly evolving, with new digital tools, regulatory updates, and data-driven strategies shaping the industry. Staying ahead requires access to reliable resources that help teams navigate the complexities of compliance, engagement, and campaign effectiveness. However, with so much information available, finding the right resources can feel overwhelming.
Providing affordable point-of-care diagnostic tools can be instrumental in quickly and efficiently assessing the well-being of all people, especially pregnant mothers. This can empower healthcare providers to be better diagnosticians and improve overall patient care, particularly for those at risk. The post Navigating Diagnostic Deserts: How Portable Ultrasound is Improving Maternal Healthcare in Africa appeared first on MedCity News.
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
An opaque system of rebates and discounts makes understanding a drug’s true price near impossible, even for experts. Can efforts to bring transparency into that system now pan out?
Neurotech Pharmaceuticals surgically implanted cell and gene therapy, Encelto, is now FDA approved to treat macular telangectasia type 2 (MacTel). Its the first therapy for this rare retinal degeneration disorder. The post Gene Therapy in an Implant: Neurotech Lands First FDA Approval in Rare Vision Disorder appeared first on MedCity News.
In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.
The full tolerance coverage method is introduced as a coverage estimation approach for assessing the uniformity of dosage units from large sample sizes, ensuring that no dosage unit exceeds the specification range.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
130 
Let's personalize your content